Libra Infusions Limited announced earnings results for the third quarter ended March 31, 2019. For the third quarter, the company announced sales was BDT 35.146 million compared to BDT 21.325 million a year ago. Operating loss was BDT 2.979 million compared to BDT 11.076 million a year ago. Net loss was BDT 17.095 million compared to BDT 15.180 million a year ago. Basic loss per share was BDT 11.38 compared to BDT 12.13 a year ago. For the nine months, sales was BDT 161.062 million compared to BDT 141.466 million a year ago. Operating income was BDT 5.154 million compared to operating loss of BDT 3.338 million a year ago. Net loss was BDT 27.147 million compared to BDT 15.829 million a year ago. Basic loss per share was BDT 18.07 compared to BDT 12.65 a year ago.